![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_c8494007663098abb5d227cb27cc738b.svg) | Sorafenib | IC50 | 68.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_c8494007663098abb5d227cb27cc738b.svg) | Sorafenib | Ki | 0.02 [1], 0.12 [2], 22.0 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_7de5848be93196a6906eba944a298431.svg) | Sunitinib | IC50 | 37.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_7de5848be93196a6906eba944a298431.svg) | Sunitinib | Ki | 2.9 [1], 9.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_9d111ca31c6b5557bbe95cc7cad92c76.svg) | Vatalanib | IC50 | 43.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_7c1f47f3c7bae38fb065c983ece631c1.svg) | Vandetanib | IC50 | 41.8 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_8a69b3902a36c5bcb114db8f49f8eabe.svg) | Semaxanib | IC50 | 884.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_1d5eba4b4bb57896dda18b1604bab021.svg) | Staurosporine | IC50 | 10.36 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_1d5eba4b4bb57896dda18b1604bab021.svg) | Staurosporine | Ki | 1.7 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_aa4ae66a17e1730306dedb6ebaeee891.svg) | 2-(Pyridin-4-Ylmethylamino)-~{n}-[3-(Trifluoromethyl)phenyl]benzamide | IC50 | 32.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_34ec291e290db2e13648ccc8dee7e3a5.svg) | Cabozantinib | IC50 | 0.48 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_173905a1d8206fe6271a8ee9486c99d9.svg) | Foretinib | IC50 | 0.9 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_e2f99194617c96946324b426e112d809.svg) | Erlotinib | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_4e38800d1c310079b3b3e65c5db78d0d.svg) | Linifanib | IC50 | 5.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_f8ca8018290f1dd80c8639283c8f8eae.svg) | 2-{[(Pyridin-4-yl)methyl]amino}-N-(quinolin-3-yl)benzamide | IC50 | 50.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_1c0dbc70a65a3eccf3e39ecce75f7f37.svg) | Pazopanib | IC50 | 30.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_ac9e30b723e2c9bf1debc2a45966acbb.svg) | 3-(1H-Indol-3-yl)-4-(3,4,5-trimethoxyphenyl)pyrrole-2,5-dione | IC50 | 2.5 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_941408e43c25b505975eab00c707db56.svg) | 1-[2-Fluoro-4-(5-methylpyrrolo[3,2-d]pyrimidin-4-yl)oxyphenyl]-3-[3-(trifluoromethyl)phenyl]urea | IC50 | 0.03 [1], 4.7 [2], 6.2 [3], 14.0 [4] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_941408e43c25b505975eab00c707db56.svg) | 1-[2-Fluoro-4-(5-methylpyrrolo[3,2-d]pyrimidin-4-yl)oxyphenyl]-3-[3-(trifluoromethyl)phenyl]urea | Ki | 0.02 [1], 0.04 [2], 4.6 [3], 23.0 [4] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_8edb893ba88c5700603edef201da4265.svg) | Nintedanib | IC50 | 5.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_3bd5dcd12d2ef57fd5cbefabf7849aa3.svg) | Gefitinib | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_4e9df3bd1ea0920231ce5d4b41666b94.svg) | Ponatinib | IC50 | 1.7 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_37acee0cd10541aa0b3bd57948b54806.svg) | Orantinib | IC50 | 680.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_969493da19549693a0acb94f703a8630.svg) | N-(4-Chlorophenyl)-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide | IC50 | 0.48 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_d82fab1028f4e0de22d7e5370ed8f8b9.svg) | 4-N-(3,5-Dimethoxyphenyl)-4-N-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]-1-N-propan-2-ylcyclohexane-1,4-diamine | IC50 | 954.99 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_86e23d55fdceb70174cbbe43cedcb982.svg) | 4-[3-Hydroxyanilino]-6,7-dimethoxyquinazoline | IC50 | 50.0 [1], 66.0 [2], 890.0 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_b63a2565bd4d512206a1c9679cacee61.svg) | 3-((4-Bromo-2,6-difluorobenzyl)oxy)-5-(3-(4-(pyrrolidin-1-yl)butyl)ureido)isothiazole-4-carboxamide | IC50 | 1.27 [1], 6.0 [2], 10.55 [3], 11.0 [4] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_13756c608c557f48b9b323793aa85ae2.svg) | MGCD-265 analog | IC50 | 1.0 [1], 6.0 [2], 10.0 [3], 26.0 [4], 30.0 [5] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_3bdf7128b3bf4b644abdbc0d5a4f70a1.svg) | N-(3-Chloro-4-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine | IC50 | 510.0 [1], 800.0 [2], 5300.0 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_580efe2e66439369c377fd174fde96fb.svg) | Ilorasertib | IC50 | 1.59 [1], 2.0 [2], 3.0 [3], 4.0 [4] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_bbb936490cb2d36df2f50d54114bf2ad.svg) | 1-[4-(4-Aminothieno[2,3-d]pyrimidin-5-yl)phenyl]-3-(3-methylphenyl)urea | IC50 | 1.0 [1], 3.0 [2], 3.02 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_0a635434a12e54ad7547c4e837fd04a9.svg) | Thienopyrimidine deriv. 11 | IC50 | 3.0 [1], 6.0 [2], 6.03 [3], 10.0 [4] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_028d833028bfab32494327ccb535efab.svg) | N-(4-Bromo-2-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine | IC50 | 460.0 [1], 1650.0 [2], 2900.0 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_8af081cfd985a9035dd01393c2589906.svg) | N-[5-(Ethylsulfonyl)-2-methoxyphenyl]-5-[3-(2-pyridinyl)phenyl]-1,3-oxazol-2-amine | IC50 | 17.1 [1], 22.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_be0c5af99f270324ab9fae747ff24082.svg) | 2-(Benzyloxy)-5-(6-methoxy-7-(2-methoxyethoxy)quinazolin-4-ylamino)cyclohexa-2,5-diene-1,4-dione | IC50 | 43.0 [1], 50.3 [2], 53.7 [3], 140.0 [4], 366.1 [5] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_ef9185a7a13072b33ea713c758313228.svg) | 2-[(3-Fluorophenyl)methoxy]-5-[[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]amino]cyclohexa-2,5-diene-1,4-dione | IC50 | 31.2 [1], 41.9 [2], 46.1 [3], 188.0 [4], 256.3 [5] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_7f1fec463c27be96312a60094829e830.svg) | 2-(4-Benzylpiperazin-1-yl)-5-[[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]amino]cyclohexa-2,5-diene-1,4-dione | IC50 | 75.5 [1], 84.8 [2], 125.4 [3], 1000.0 [4] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_79c68d7c28ef24a0dbc247a1a88b6308.svg) | 2-(1,3-Difluoropropan-2-yloxy)-5-[[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]amino]cyclohexa-2,5-diene-1,4-dione | IC50 | 9.1 [1], 18.5 [2], 21.3 [3], 24.8 [4], 212.0 [5] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_eaba2c3e0c5cd001a527b05161738b1b.svg) | 2-[[6-Methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]amino]-5-methylsulfanylcyclohexa-2,5-diene-1,4-dione | IC50 | 30.1 [1], 43.3 [2], 114.7 [3], 456.0 [4], 1000.0 [5] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_f8d643415bdbf58d57a448644ef36aa3.svg) | 2-(4-Imidazol-1-ylphenoxy)-5-[[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]amino]cyclohexa-2,5-diene-1,4-dione | IC50 | 5.8 [1], 7.6 [2], 310.0 [3], 1000.0 [4] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_29a3ff7bdfcdeb55f4bea39ca660e03b.svg) | 2-(1,3-Difluoropropan-2-yloxy)-5-[[6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-yl]amino]cyclohexa-2,5-diene-1,4-dione | IC50 | 3.7 [1], 5.1 [2], 6.9 [3], 11.2 [4], 189.0 [5] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_8a10ad475f5e375c69dc7d5b72e4d90f.svg) | 2-[[6-Methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]amino]-5-propan-2-yloxycyclohexa-2,5-diene-1,4-dione | IC50 | 481.0 [1], 491.3 [2], 542.9 [3], 1000.0 [4] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_62411c4e68fdb2c0e658ae9cd4ddcbad.svg) | 2-Methoxy-5-(6-methoxy-7-(2-methoxyethoxy)quinazolin-4-ylamino)cyclohexa-2,5-diene-1,4-dione | IC50 | 25.0 [1], 240.9 [2], 436.3 [3], 558.6 [4], 1000.0 [5] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_1e1cd0fe80b42bb76c531aefc89dec7e.svg) | 3-Chloro-2-methoxy-5-{[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]amino}benzo-1,4-quinone | IC50 | 1.0 [1], 5.1 [2], 20.9 [3], 466.0 [4] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_0a6ac3c6927f8440bbf40be2a8c65b6a.svg) | 2-Methoxy-5-({6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-yl}amino)benzo-1,4-quinone | IC50 | 5.0 [1], 129.9 [2], 239.3 [3], 239.7 [4], 3020.7 [5] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_8b382f643ff171dd48442daa310a22c6.svg) | 2-Methoxy-5-{[6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-yl]amino}benzo-1,4-quinone | IC50 | 3.0 [1], 158.6 [2], 271.8 [3], 406.3 [4], 1274.0 [5] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_41eeee4c34ed05e1cc8c3edeb28dbd1c.svg) | 2-[[6-Methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]amino]-5-(pyridin-3-ylmethoxy)cyclohexa-2,5-diene-1,4-dione | IC50 | 88.7 [1], 107.8 [2], 110.5 [3], 193.0 [4], 1000.0 [5] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_3bbbd051d98467a9923bd3897711d93f.svg) | 2-[[6-Methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]amino]-5-(5-methyl-2-oxo-1,3-oxazolidin-3-yl)cyclohexa-2,5-diene-1,4-dione | IC50 | 7.3 [1], 10.3 [2], 59.7 [3], 1000.0 [4] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_8e42bb955684b8f08202ea079b00bc19.svg) | N'-(2,5-Dimethoxyphenyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]-N-propan-2-ylethane-1,2-diamine | IC50 | 1000.0 [1], 1698.24 [2], 10000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_b2d54f313fd6fae3559ad99a1d264705.svg) | Imatinib | IC50 | 25000.0 [1], 25800.0 [2], 27186.0 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_c77eb69f87d46b4d00314a6bfb851cf8.svg) | Crizotinib | IC50 | 1000.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_d2aaae557a3df420b61b69998679cc44.svg) | Dorsomorphin | IC50 | 4.0 [1], 21.8 [2], 25.14 [3], 220.0 [4] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_e1bd3c1d60717a09fae0532edc016b5c.svg) | Axitinib | IC50 | 0.1 [1], 0.2 [2], 0.25 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_e1bd3c1d60717a09fae0532edc016b5c.svg) | Axitinib | Ki | 3.8 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_892aa79f14eda2e212e853914442f44b.svg) | 3-[(3-(2-Carboxyethyl)-4-methylpyrrol-2-YL)methylene]-2-indolinone | IC50 | 20.0 [1], 50.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_e68e8f660a42b0d769ec0962d14c3289.svg) | Brivanib | IC50 | 25.0 [1], 26.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_e68e8f660a42b0d769ec0962d14c3289.svg) | Brivanib | Ki | 26.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_ae3c621c3ca0049e7a4045efa2e650e7.svg) | Tivozanib | IC50 | 0.16 [1], 2.14 [2], 340.0 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_bfd85af270caa82a688349ad39ce47ce.svg) | 3-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]-3-fluorophenyl}-1-(2-phenylacetyl)thiourea | IC50 | 32.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_bfd85af270caa82a688349ad39ce47ce.svg) | 3-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]-3-fluorophenyl}-1-(2-phenylacetyl)thiourea | Ki | 103.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_f1099aa3bd39876799914a83803e440e.svg) | Tak-593 | IC50 | 0.09 [1], 0.95 [2], 1.1 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_a47a95df2c07aaf70d5a2f3dce77d01e.svg) | 6-(4-Methoxyphenyl)-3-(3-thienyl)-pyrazolo(1,5-a)pyrimidine | IC50 | 19.0 [1], 185.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_27155136dbc077658c8857b4cc311fec.svg) | 4-[2-[4-(3-Phenylpyrazolo[1,5-a]pyrimidin-6-yl)phenoxy]ethyl]morpholine | IC50 | 9.0 [1], 32.0 [2], 234.5 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_829d9468648eaacd7ae7ad912dac6a2f.svg) | N-[4-(6,7-Dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-1,5-dimethyl-3-oxo-2-phenylpyrazole-4-carboxamide | IC50 | 7.8 [1], 10.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_3675ea77fc19d393771a33a213dcb993.svg) | Exelixis | IC50 | 0.04 [1], 1.9 [2], 7.0 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_6c77ec0d5dc9ee628942395e9056e052.svg) | 1-[4-(6,7-Dimethoxy-quinazolin-4-yloxy)-phenyl]-3-(4-methoxy-phenyl)-urea | IC50 | 2.2 [1], 70.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_20ab18b8c16e5f284f7c3ab51a4a7a8f.svg) | N-Cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide | IC50 | 0.6 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_969dba429fd4e580980eb0f30b530c40.svg) | 3-(2-Aminoquinazolin-6-Yl)-4-Methyl-N-[3-(Trifluoromethyl)phenyl]benzamide | IC50 | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_aad5240e9c96fb698e391fe66cef5fea.svg) | 4-N-(3-Bromophenyl)-6-[(2-methylphenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 200.0 [1], 250.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_4e53db16979c93e82f7fbd654a494204.svg) | 4-N-(3-Bromophenyl)-6-[(2,5-dimethoxyphenyl)methyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine | IC50 | 600.0 [1], 620.0 [2], 45400.0 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_c3070d16433dd3bdacf02c9b820a59eb.svg) | Thienopyrimidine deriv. 20 | IC50 | 28.0 [1], 34.67 [2], 35.0 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_3eb7153698ad5980c3abc934fde584f1.svg) | Thienopyrimidine deriv. 24 | IC50 | 10.0 [1], 52.0 [2], 52.48 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_312004a37ba76154d5aaf6493506be15.svg) | Thienopyrimidine deriv. 91 | IC50 | 2.0 [1], 19.0 [2], 19.05 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_48cbc600be7e69bce913ec1d49cf9932.svg) | 2,4-Difluoro-N-methoxy-5-[[6-(5-methyl-1,3,4-oxadiazol-2-yl)-5-propan-2-ylpyrrolo[2,1-f][1,2,4]triazin-4-yl]amino]benzamide | IC50 | 18.0 [1], 86.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_ede9deccee3e0fe5ee09ad5ae63b5fae.svg) | 1-(4-(4-Aminothieno[3,2-c]pyridin-3-yl)phenyl)-3-m-tolylurea | IC50 | 9.0 [1], 32.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_899d631a52defa84d00d786eadc5ecb0.svg) | Pyrazolo[1,5-a]pyrimidine 4e | IC50 | 3.0 [1], 4.0 [2], 18.0 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_d809c329dca87777cbba60aa03c11aa1.svg) | N-[3-[2-(Cyclopropanecarbonylamino)imidazo[1,2-b]pyridazin-6-yl]oxyphenyl]-2,5-dimethylpyrazole-3-carboxamide | IC50 | 0.19 [1], 1.4 [2], 1.8 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_307d4717b3cfc7135f7628d03cf812c5.svg) | N-(5-Tert-butyl-1,2-oxazol-3-yl)-5-(6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-4-yloxy)indole-1-carboxamide | IC50 | 3.0 [1], 9.0 [2], 59.0 [3], 59.4 [4] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_fc068c616f1ddbc92883a580a0c928dc.svg) | Thienopyrimidine deriv. 96 | IC50 | 3.0 [1], 3.02 [2], 9.0 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_63e0b5f8bab9f5a54d94fb2e6432009e.svg) | 1-[4-(3-Amino-1H-pyrazolo[3,4-c]pyridin-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea | IC50 | 1.0 [1], 2.1 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_5e70ccd7255b28b593b10741220db9a9.svg) | 1-[4-(3-Amino-1H-pyrazolo[3,4-c]pyridin-4-yl)phenyl]-3-(3-methylphenyl)urea | IC50 | 0.6 [1], 0.7 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_bb191a0e85d0d74092d00647f020eaa9.svg) | 1-[4-(3-Amino-1-methylpyrazolo[3,4-c]pyridin-4-yl)phenyl]-3-(3-methylphenyl)urea | IC50 | 1.8 [1], 4.6 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_ee6cad303e92980387e85a2b3ca10b25.svg) | 1-[4-(3-Amino-2H-pyrazolo[3,4-b]pyridin-4-yl)phenyl]-3-(4-fluoro-3-methylphenyl)urea | IC50 | 1.1 [1], 1.2 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_56a36f595580881b4fe5a59e06f40a4a.svg) | 1-[4-(3-Amino-2H-pyrazolo[3,4-b]pyridin-4-yl)phenyl]-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea | IC50 | 2.4 [1], 7.9 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_6aac17d9fc017ba02048f4e8ee28e078.svg) | 1-[4-(3-Amino-1-methylpyrazolo[3,4-c]pyridin-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea | IC50 | 3.0 [1], 7.7 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_90bedb32f1b3d150ab91186f4a5795dc.svg) | 1-[4-(3-Amino-1-methylpyrazolo[3,4-c]pyridin-4-yl)phenyl]-3-(3-chlorophenyl)urea | IC50 | 1.5 [1], 8.8 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_e2cb2456fd758ca196e9710216e988ff.svg) | 1-(4-(4-Amino-7-phenylthieno[3,2-c]pyridin-3-yl)phenyl)-3-m-tolylurea | IC50 | 13.0 [1], 33.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_d566ce1b6a56f10f242a970189ae6709.svg) | 1-(3-Methylphenyl)-3-[[5-[6-[(4-methylpiperazin-1-yl)methyl]-2,4-dihydroindeno[1,2-c]pyrazol-3-yl]thiophen-2-yl]methyl]urea | IC50 | 61.0 [1], 146.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_4ecde9a8132b1944040168137099401d.svg) | 1-Methyl-3-(3-methylphenyl)-1-[[5-[6-[(4-methylpiperazin-1-yl)methyl]-2,4-dihydroindeno[1,2-c]pyrazol-3-yl]thiophen-2-yl]methyl]urea | IC50 | 146.0 [1], 159.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_3d943e039b3c63f36a916b669aa311ac.svg) | 5-Phenyl-N-[5-(pyrrolidin-1-ylmethyl)pyridin-2-yl]-1,3-thiazol-2-amine | IC50 | 6.0 [1], 24.0 [2], 28.0 [3] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_b3b54431d6bd3cfb928c9488c01b4b11.svg) | N-[6-[3-[[3-(Trifluoromethyl)benzoyl]amino]phenoxy]imidazo[1,2-b]pyridazin-2-yl]oxane-4-carboxamide | IC50 | 1.1 [1], 3.1 [2], 6.9 [3], 10.0 [4] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_492c4964959dc4b0310bfcf3cf736998.svg) | 1-[4-(3-Amino-2H-pyrazolo[3,4-b]pyridin-4-yl)phenyl]-3-[3-(trifluoromethyl)phenyl]urea | IC50 | 1.7 [1], 2.6 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_43f6fe2bbb472df9a08ee97d9727f732.svg) | 1-[4-(3-Amino-1H-pyrazolo[3,4-c]pyridin-4-yl)phenyl]-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea | IC50 | 1.0 [1], 1.3 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_f818b0d21356159e3846198553041487.svg) | 1-[4-(3-Amino-2H-pyrazolo[3,4-b]pyridin-4-yl)phenyl]-3-(3,5-difluorophenyl)urea | IC50 | 6.3 [1], 8.1 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_f90950ca11904839b7e8065cafe802dd.svg) | 2-(Dimethylamino)-5-{[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]amino}benzo-1,4-quinone | IC50 | 31.0 [1], 1144.1 [2], 5000.3 [3], 20000.0 [4] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_525e3e6b61955a486945de690aa3bac4.svg) | 1-[4-(3-Amino-1H-pyrazolo[4,3-c]pyridin-4-yl)phenyl]-3-(3-chlorophenyl)urea | IC50 | 12.0 [1], 46.0 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_455a3450be86abc05074a0892c2f4386.svg) | 2-[[6-Methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]amino]-5-(2-phenoxyethoxy)cyclohexa-2,5-diene-1,4-dione | IC50 | 1.7 [1], 4.8 [2], 117.8 [3], 1000.0 [4] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_197de2c132c4cdc17609af29a74ff619.svg) | 1-[4-(3-Amino-2H-pyrazolo[3,4-b]pyridin-4-yl)phenyl]-3-(3-methoxyphenyl)urea | IC50 | 3.8 [1], 3.9 [2] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_312de12352a79cfdb5d1072e8b646c69.svg) | 2-[[6-Methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-yl]amino]-5-phenylmethoxycyclohexa-2,5-diene-1,4-dione | IC50 | 13.6 [1], 26.1 [2], 29.5 [3], 536.0 [4] |
![](https://images.aatbio.com/dataset/ic50/vascular-endothelial-growth-factor-receptor-2_bf17242c186a2e4b2a0516dc28977893.svg) | 2-Ethoxy-5-{[6-methoxy-7-(2-methoxyethoxy)quinazolin-4-yl]amino}benzo-1,4-quinone | IC50 | 1000.0 [1] |